Novo CEO pressed by Senate to cut selling prices of obesity, diabetes medications CEO Lars Fruergaard Jørgensen told lawmakers the corporate would think about new talks with insurers regarding the checklist charges of Wegovy and copyright when they pledge to keep the medicines on their own formularies. You should not https://busch-peach-calories49493.canariblogs.com/everything-about-healthcare-news-45861174